Comorbid anxiety symptoms in children with pervasive developmental disorders.

Kiddie-SADS Reveals High Rates of DSM-IV Disorders in Children and Adolescents with Autism Spectrum Disorders

Prevalence of current comorbid DSM-IV disorders was assessed in a special school population of children and adolescents with ASD (N = 71, age 6.0-17.9 years), representing all cognitive levels and main ASD subgroups. Symptoms were assessed through parent interview and association to child characteristics was explored. Seventy-two percent was diagnosed with at least one comorbid disorder. Anxiet...

Cognitive Behavioral Therapy is an Effective Approach to Reduce Anxiety Symptoms and Comorbid Anxiety Disorders in Children with Autism Spectrum Disorders and Anxiety when compared to No Treatment

Comorbid ADHD and anxiety affect social skills group intervention treatment efficacy in children with autism spectrum disorders.

OBJECTIVE To assess the influence of psychiatric comorbidity on social skill treatment outcomes for children with autism spectrum disorders (ASDs). METHODS A community sample of 83 children (74 males, 9 females) with an ASD (mean age = 9.5 yr; SD = 1.2) and common comorbid disorders participated in 10-week social skills training groups. The first 5 weeks of the group focused on conversation s...

Parental Alexithymia, Depression and Anxiety Levels of Children with Neurodevelopmental Disorders: A Comparative Study with Pervasive Developmental Disorders and ADHD

BACKGROUND: Recent studies showed that individuals with neurodevelopmental disorders and their relatives have problems to express and recognize emotions but there is a lack of studies concerning alexithymia levels and relationships between parental alexithymia and depression-anxiety symptoms in these groups. OBJECTIVE: We aimed to determine alexithymia, depression, anxiety levels of parents in ...

Psychopathology in children and adolescents with ASD without mental retardation.

This study analyzes subclinical psychopathology in children and adolescents with autism spectrum disorders (ASD) without mental retardation with no comorbid disorder, assessed by an extensive general psychopathology interview. The K-SADS-PL was administered to a group of 25 patients with ASD (mean age = 12.80 ± 2.86 years) and 25 healthy controls (mean age 12.52 ± 2.86 years). Significant diffe...